Supervised drug-use centres key to reducing harm says EU expert

Supervised centres where marginalised people can legally take drugs should be seen as 'key instruments' in reducing harm, according to the head of the EU drug agency.

Supervised centres where marginalised people can legally take drugs should be seen as “key instruments” in reducing the harm caused by substances, the head of the EU drug agency has said.

Alexis Goosdeel, director of the European Monitoring Centre for Drugs and Drug Addiction, said this was from seeing the work of drug consumption rooms (DCRs) across the EU, with some 100 centres now in operation.